311 studies found for:    Open Studies | "Urinary Bladder Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Pilot Study Evaluating the Efficacy of Certolizumab Pegol for Interstitial Cystitis
Condition: Cystitis, Interstitial
Interventions: Biological: Certolizumab pegol;   Drug: Placebo
22 Not yet recruiting Aqueduct Irrigation System Clinical Protocol: Medical Device Investigational Plan
Conditions: Prostatic Hyperplasia;   Kidney Calculi;   Bladder Tumors
Intervention: Device: Aqueduct
23 Recruiting Cabozantinib Plus Nivolumab (CaboNivo) Alone or in Combination With Ipilimumab (CaboNivoIpi) in Patients With Advanced/Metastatic Urothelial Carcinoma and Other Genitourinary Tumors
Conditions: Urothelial Cancer;   Bladder Cancer;   Genitourinary Cancer;   Urogenital Neoplasms;   Urogenital Cancer
Interventions: Drug: Cabozantinib;   Drug: Nivolumab;   Drug: Ipilimumab
24 Not yet recruiting Ultrasound and Biomarker Tests in Predicting Cancer Aggressiveness in Tissue Samples of Patients With Bladder Cancer
Conditions: Bladder Papillary Urothelial Carcinoma;   Stage 0a Bladder Urothelial Carcinoma;   Stage 0is Bladder Urothelial Carcinoma;   Stage I Bladder Cancer With Carcinoma In Situ;   Stage I Bladder Urothelial Carcinoma;   Stage II Bladder Urothelial Carcinoma;   Stage III Bladder Urothelial Carcinoma;   Stage IV Bladder Urothelial Carcinoma
Intervention: Other: Laboratory Biomarker Analysis
25 Not yet recruiting The PK Characteristics of the JLP-1207(Solifenacin/Tamsulosin 5mg/0.2mg) and Co-administration of Solifenacin and Tamsulosin in Healthy Male Volunteers.
Conditions: LUTS(Lower Urinary Tract Symptoms);   Benign Prostatic Hyperplasia;   Overactive Bladder
Interventions: Drug: JLP-1207;   Drug: Solifenacin 5mg + Tamsulosin 0.2mg
26 Not yet recruiting CIK in Treating Patients With Bladder Cancer
Condition: Urinary Bladder Neoplasms
Intervention: Biological: Cytokine-induced Killer Cells
27 Recruiting Clinical Study to Assess the Efficacy and Safety of THVD-201 in Patients With OAB
Condition: Overactive Bladder
Interventions: Drug: THVD-201;   Drug: Placebo(For THVD-201);   Drug: Detrusitol 2mg tablet;   Drug: Placebo(For Detrusitol 2mg tablet)
28 Recruiting Cystoscopic Ablation Via RF Energy Clinical Trial (CARET 2)
Condition: Overactive Bladder
Intervention: Device: Amphora OAB Device 3.0 mm
29 Not yet recruiting MPDL3280A-treatment-IST-UMCG
Conditions: Bladder Cancer;   Non Small Cell Lung Cancer;   Breast Cancer
Intervention: Drug: MPDL3280A
30 Not yet recruiting Brain Areas Involved in Bladder Filling and Contraction
Condition: Urinary Bladder, Overactive
Interventions: Procedure: Uroflowmetry;   Device: fMRI
31 Not yet recruiting RITE-EUROPE (Radiofrequency-Induced Thermochemotherapy Effect-EUROPE)
Condition: Bladder Cancer
Intervention: Other: Synergo® RITE + MMC
32 Not yet recruiting Prospective Study for Patient Perception of Treatment Satisfaction After Switching to Mirabegron in Patients With Overactive Bladder Who Were Unsatisfied With Efficacy of Antimuscarinic Therapy or Adverse Event.
Condition: Overactive Bladder
Intervention: Drug: mirabegron 50mg
33 Recruiting Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
Conditions: Urinary Bladder, Overactive;   Pain;   Lower Urinary Tract Symptoms
Interventions: Drug: Mirabegron;   Drug: Placebo
34 Not yet recruiting Impact of Positron Emission Tomography (PET) Imaging in Muscle-invasive Urothelial Carcinoma of the Bladder Staging
Condition: Muscle-invasive Bladder Cancer
Intervention: Other: Whole-body FDG PET-CT
35 Recruiting T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies
Conditions: Bladder Carcinoma;   Breast Cancer;   Esophagus Carcinoma;   Lung Cancer;   Melanoma;   Multiple Myeloma;   Neuroblastoma;   Ovarian Cancer;   Synovial Sarcoma;   Other Metastatic Solid Cancers
Interventions: Drug: Cyclophosphamide;   Drug: Fludarabine;   Biological: Anti-NY ESO-1 TCR-transduced T cells
36 Not yet recruiting MPDL3280A-imaging-IST-UMCG
Conditions: Breast Cancer;   Bladder Cancer;   Non Small Cell Lung Cancer
Intervention: Other: 89Zr-MPDL-3280A-PET scans
37 Recruiting Treatment, Parallel Assignment, Double Blind (Subject, Outcomes Assessor), Efficacy Study
Condition: Overactive Bladder
Interventions: Device: Electroacupuncture;   Device: Sham Electroacupuncture;   Drug: Solifenacin Succinate
38 Recruiting Randomized Trial of Tibial Nerve Stimulation Versus Pelvic Floor Exercises for Treatment of Overactive Bladder
Condition: Urge Incontinence
Intervention: Other: "Tibial stimulation" and "pelvic floor exercises"
39 Recruiting IMvigor 010 Study: Anti-Programmed Death-Ligand 1 (PD-L1) Antibody MPDL3280A Treatment Versus Observation as Adjuvant Therapy in Patients With PD-L1 Positive, High Risk Muscle Invasive Bladder Cancer After Cystectomy
Condition: Bladder Cancer, Cancer
Intervention: Biological: MPDL3280A
40 Not yet recruiting Study of Tumour Focused Radiotherapy for Bladder Cancer
Condition: Bladder Cancer
Interventions: Radiation: WBRT;   Radiation: SART;   Radiation: DART

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years